Related Experiment Video
Updated: Mar 14, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
[The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects]
Airi Tarutani1, Shin-Ichi Hisanaga, Masato Hasegawa
1Department of Dementia and Higher Brain Function, Tokyo Metropolitan, Institute of Medical Science.
Abstract:
Intracellular abnormal protein deposits, such as tau, α-synuclein and TDP-43, are the hallmark of many neurodegenerative diseases, and the distributions of these pathological proteins are closely correlated with disease symptoms and progression. A growing body of evidence strongly suggests that these abnormal proteins have prion-like properties: they convert normal proteins into abnormal forms, self-propagate through neuronal networks, and then spread in the brain. This prion-like propagation of abnormal proteins may account for the diversity, selective degeneration and disease progression seen in neurodegenerative diseases, although the molecular mechanism remains uncertain the molecular details of this mechanism. This review describes recent studies on prion-like properties of abnormal proteins in vitro, in cells and in animal experimental models.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Neural Regulation
Parkinson's Disease: Overview
Subviral Agents
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

